Surgical & Medical Instruments & Apparatus Industry - SEC Form 4 Insider Trading Screener
Manufacturing Sector - Specialty Instruments - Surgical & Medical Instruments & Apparatus
100 results - 
- 
- 
- 
- 
- 
- - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-10-26 | HAE | Haemonetics Corp | Goldstein Dan | VP, Corporate Controller | S - Sale | $106.00 | -100 | 1,749 | -5% | -$10,600 | ||||||
2020-10-26 | HAE | Haemonetics Corp | Burke William P. Mr. | EVP, CFO | S - Sale | $106.00 | -1,161 | 11,337 | -9% | -$123,066 | ||||||
| D | 2020-10-22 | ISR | Isoray, Inc. | Austin Mark John | Controller, Prin Fin, Acct Off | P - Purchase | $0.52 | +19,230 | 35,230 | +120% | +$10,000 | |||||
| D | 2020-10-22 | ISR | Isoray, Inc. | Krachon Michael | EVP of Sales, Marketing | P - Purchase | $0.52 | +28,844 | 133,844 | +27% | +$14,999 | |||||
| D | 2020-10-22 | ISR | Isoray, Inc. | Hunt Jonathan Robert | CFO | P - Purchase | $0.52 | +67,306 | 67,306 | New | +$34,999 | |||||
| D | 2020-10-22 | ISR | Isoray, Inc. | Cavanagh William | Chief R, D Officer | P - Purchase | $0.52 | +7,692 | 27,692 | +38% | +$4,000 | |||||
| D | 2020-10-22 | ISR | Isoray, Inc. | McCormick Michael W | Dir | P - Purchase | $0.52 | +19,230 | 41,230 | +87% | +$10,000 | |||||
| D | 2020-10-22 | ISR | Isoray, Inc. | Hoffmann Alan | Dir | P - Purchase | $0.52 | +19,230 | 64,230 | +43% | +$10,000 | |||||
| D | 2020-10-22 | ISR | Isoray, Inc. | Vitale Philip J | Dir | P - Purchase | $0.52 | +20,000 | 130,000 | +18% | +$10,400 | |||||
| D | 2020-10-22 | ISR | Isoray, Inc. | Woods Lori A | CEO | P - Purchase | $0.52 | +48,076 | 590,576 | +9% | +$25,000 | |||||
2020-10-26 | HRC | Hill-Rom Holdings, Inc. | Frank Andreas G | SVP, Pres Front Line Care | S - Sale | $91.45 | -5,500 | 12,111 | -31% | -$502,975 | ||||||
| D | 2020-10-26 | TFX | Teleflex Inc | Klasko Stephen K. M.D. | Dir | S - Sale+OE | $361.38 | -200 | 9,001 | -2% | -$72,276 | |||||
2020-10-23 | DXCM | Dexcom Inc | Pacelli Steven Robert | EVP Strategy, Corporate Dev | S - Sale | $403.18 | -1,079 | 61,939 | -2% | -$435,030 | ||||||
2020-10-23 | DXCM | Dexcom Inc | Doubleday Richard | EVP Chief Commercial Officer | S - Sale | $403.10 | -1,110 | 45,702 | -2% | -$447,444 | ||||||
2020-10-22 | NVRO | Nevro Corp | Pellegrini Niamh Louise | Chief Commercial Officer | S - Sale | $165.00 | -1,817 | 30,328 | -6% | -$299,805 | ||||||
2020-10-23 | HAE | Haemonetics Corp | Basil Michelle L | EVP, GC | S - Sale | $106.58 | -181 | 15,992 | -1% | -$19,291 | ||||||
2020-10-20 | INSP | Inspire Medical Systems, Inc. | Buchholz Richard | CFO | S - Sale | $122.84 | -3,000 | 75,171 | -4% | -$368,510 | ||||||
| D | 2020-10-20 | VAPO | Vapotherm Inc | Ramade Gregoire | Officer | S - Sale+OE | $30.62 | -2,000 | 13,114 | -13% | -$61,240 | |||||
2020-10-19 | NVRO | Nevro Corp | Pellegrini Niamh Louise | Chief Commercial Officer | S - Sale | $155.00 | -1,000 | 32,145 | -3% | -$155,000 | ||||||
2020-10-19 | HRC | Hill-Rom Holdings, Inc. | Frank Andreas G | SVP, Pres Front Line Care | S - Sale | $89.90 | -5,500 | 17,611 | -24% | -$494,450 | ||||||
2020-10-19 | SIBN | Si-Bone, Inc. | Freund John Gordon | Dir, 10% | S - Sale | $22.00 | -190,053 | 2,180,217 | -8% | -$4,181,166 | ||||||
2020-10-20 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $8.54 | +700 | 16,083,589 | 0% | +$5,978 | ||||||
| M | 2020-10-16 | SWAV | Shockwave Medical, Inc. | Papiernik Antoine | Dir | S - Sale | $79.13 | -16,619 | 1,468,707 | -1% | -$1,315,062 | |||||
| M | 2020-10-16 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | COB, Pres, CEO | S - Sale | $25.22 | -10,092 | 416,870 | -2% | -$254,505 | |||||
2020-10-16 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Chief Commercial Officer | S - Sale | $23.53 | -587 | 70,492 | -1% | -$13,813 | ||||||
2020-10-16 | SIBN | Si-Bone, Inc. | Pisetsky Michael A | GC, Chief Compliance Officer | S - Sale | $23.53 | -247 | 49,005 | -1% | -$5,812 | ||||||
2020-10-16 | DRIO | Dariohealth Corp. | Karah Hila | Dir | P - Purchase | $0.00 | +1,372 | 49,143 | +3% | +$0 | ||||||
2020-10-16 | DRIO | Dariohealth Corp. | Raphael Erez | CEO | P - Purchase | $0.00 | +7,187 | 566,376 | +1% | +$0 | ||||||
2020-10-15 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $176.72 | -2,500 | 84,275 | -3% | -$441,800 | ||||||
2020-10-15 | DXCM | Dexcom Inc | Foletta Mark G | Dir | S - Sale | $396.82 | -1,000 | 15,097 | -6% | -$396,819 | ||||||
2020-10-15 | RMD | Resmed Inc | Douglas Robert Andrew | Pres, COO ResMed Inc. | S - Sale | $176.72 | -1,125 | 206,933 | -1% | -$198,810 | ||||||
| D | 2020-10-16 | NSPR | Inspiremd, Inc. | Roubin Gary S | Dir | P - Purchase | $0.45 | +222,223 | 461,173 | +93% | +$100,000 | |||||
| D | 2020-10-15 | SWAV | Shockwave Medical, Inc. | Puckett Dan | CFO | S - Sale+OE | $74.30 | -12,000 | 37,308 | -24% | -$891,569 | |||||
| D | 2020-10-15 | SWAV | Shockwave Medical, Inc. | Zacharias Isaac | Chief Commercial Officer | S - Sale+OE | $73.24 | -4,000 | 58,550 | -6% | -$292,950 | |||||
| D | 2020-10-14 | SILK | Silk Road Medical Inc | Buchanan Lucas W. | COO, CFO | S - Sale+OE | $65.21 | -9,600 | 124,545 | -7% | -$626,020 | |||||
| M | 2020-10-08 | INSP | Inspire Medical Systems, Inc. | Nelson Marilyn C | Dir | S - Sale | $130.92 | -26,000 | 148,206 | -15% | -$3,403,977 | |||||
| D | 2020-10-16 | ICUI | Icu Medical Inc/de | Swinney Robert S | Dir | S - Sale+OE | $202.22 | -277 | 23,630 | -1% | -$56,015 | |||||
2020-10-15 | GNMK | Genmark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering, Tech Dev | S - Sale | $11.83 | -500 | 209,765 | 0% | -$5,915 | ||||||
2020-10-13 | PEN | Penumbra Inc | O'Rourke Bridget | Dir | S - Sale | $207.58 | -65 | 3,193 | -2% | -$13,493 | ||||||
| D | 2020-10-13 | TNDM | Tandem Diabetes Care Inc | Berger David B | EVP, Chief Legal, Compliance | S - Sale+OE | $119.25 | -5,000 | 4,766 | -51% | -$596,250 | |||||
| D | 2020-10-13 | TNDM | Tandem Diabetes Care Inc | Vosseller Leigh | EVP, CFO | S - Sale+OE | $120.87 | -10,000 | 4,665 | -68% | -$1,208,728 | |||||
| D | 2020-10-13 | TNDM | Tandem Diabetes Care Inc | Sheridan John F | Pres, CEO | S - Sale+OE | $121.31 | -15,000 | 3,756 | -80% | -$1,819,658 | |||||
2020-10-12 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale | $212.64 | -8,000 | 973,582 | -1% | -$1,701,146 | ||||||
2020-10-09 | PEN | Penumbra Inc | Kassing Don W. | Dir | S - Sale | $209.76 | -712 | 9,493 | -7% | -$149,347 | ||||||
2020-10-14 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $8.89 | +500 | 16,102,889 | 0% | +$4,445 | ||||||
2020-10-12 | HRC | Hill-Rom Holdings, Inc. | Frank Andreas G | SVP, Pres Front Line Care | S - Sale | $89.48 | -5,500 | 23,111 | -19% | -$492,140 | ||||||
2020-10-12 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $9.47 | -89,999 | 571,840 | -14% | -$852,291 | ||||||
| M | 2020-10-09 | SWAV | Shockwave Medical, Inc. | Papiernik Antoine | Dir | S - Sale | $79.00 | -1,581 | 1,485,326 | 0% | -$124,899 | |||||
| DM | 2020-10-09 | NVRO | Nevro Corp | Pellegrini Niamh Louise | Chief Commercial Officer | S - Sale+OE | $150.63 | -1,750 | 33,145 | -5% | -$263,603 | |||||
| D | 2020-10-12 | SILK | Silk Road Medical Inc | Rogers Erica J. | Pres, CEO | S - Sale+OE | $66.16 | -20,044 | 195,451 | -9% | -$1,326,133 | |||||
| M | 2020-10-09 | NVRO | Nevro Corp | Demane Michael F | Dir | S - Sale | $150.35 | -21,432 | 374,261 | -5% | -$3,222,287 | |||||
| D | 2020-10-09 | PODD | Insulet Corp | Spears Michael P | SVP, RA, Compliance | S - Sale+OE | $246.10 | -22,257 | 8,947 | -71% | -$5,477,448 | |||||
2020-10-09 | DRIO | Dariohealth Corp. | Kamer Allen | Dir | P - Purchase | $0.00 | +10,000 | 97,209 | +11% | +$0 | ||||||
| D | 2020-10-09 | ICUI | Icu Medical Inc/de | Jain Vivek | COB, CEO | S - Sale+OE | $195.00 | -11,500 | 66,241 | -15% | -$2,242,500 | |||||
2020-10-09 | ATRC | Atricure, Inc. | Seith Douglas J | COO | S - Sale | $40.09 | -29,161 | 132,997 | -18% | -$1,169,064 | ||||||
2020-10-02 | DYNT | Dynatronics Corp | Baker Brian D. | Dir | P - Purchase | $0.00 | +7,692 | 60,087 | +15% | +$0 | ||||||
2020-10-02 | DYNT | Dynatronics Corp | Provco Ventures 1 LP | 10% | P - Purchase | $0.00 | +54,806 | 913,852 | +6% | +$0 | ||||||
2020-10-02 | DYNT | Dynatronics Corp | Larkin Brian | Dir | P - Purchase | $0.00 | +5,449 | 169,879 | +3% | +$0 | ||||||
2020-10-02 | DYNT | Dynatronics Corp | Enright Erin S. | Dir | P - Purchase | $0.00 | +109,674 | 1,541,192 | +8% | +$0 | ||||||
2020-10-02 | DYNT | Dynatronics Corp | Essig Stuart | 10% | P - Purchase | $0.00 | +109,674 | 1,541,192 | +8% | +$0 | ||||||
2020-10-08 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, People, Culture, GC | S - Sale | $8.62 | -62,731 | 985,361 | -6% | -$540,579 | ||||||
| D | 2020-10-07 | TNDM | Tandem Diabetes Care Inc | Hansen Brian B | EVP, CHIEF COMMERCIAL OFFICER | S - Sale+OE | $117.76 | -15,000 | 4,665 | -76% | -$1,766,438 | |||||
| D | 2020-10-07 | GNMK | Genmark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, Clin Affairs | S - Sale+OE | $15.00 | -69,749 | 250,121 | -22% | -$1,046,235 | |||||
2020-10-09 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $8.24 | +400 | 16,122,389 | 0% | +$3,296 | ||||||
| D | 2020-10-08 | ICAD | Icad Inc | Stevens Stacey M | Pres | S - Sale+OE | $10.00 | -15,873 | 171,788 | -8% | -$158,730 | |||||
2020-10-06 | HRC | Hill-Rom Holdings, Inc. | Frank Andreas G | SVP, Pres Front Line Care | S - Sale | $87.50 | -5,500 | 28,611 | -16% | -$481,250 | ||||||
2020-10-06 | ATRC | Atricure, Inc. | Collar Mark A | Dir | S - Sale | $40.00 | -2,330 | 83,858 | -3% | -$93,200 | ||||||
| D | 2020-10-05 | PODD | Insulet Corp | Petrovic Shacey | Pres, CEO | S - Sale+OE | $233.91 | -15,000 | 106,308 | -12% | -$3,508,650 | |||||
| M | 2020-10-05 | SWAV | Shockwave Medical, Inc. | Papiernik Antoine | Dir | S - Sale | $77.13 | -29,000 | 1,486,907 | -2% | -$2,236,688 | |||||
2020-10-02 | ARAY | Accuray Inc | Levine Joshua | Pres, CEO | S - Sale | $2.43 | -15,370 | 764,943 | -2% | -$37,366 | ||||||
2020-10-02 | ARAY | Accuray Inc | Hamamatsu Shigeyuki | SVP, CFO | S - Sale | $2.43 | -8,641 | 177,003 | -5% | -$21,007 | ||||||
| D | 2020-10-05 | RMD | Resmed Inc | Pendarvis David | Chief Administrative Officer | S - Sale+OE | $170.07 | -5,919 | 136,128 | -4% | -$1,006,621 | |||||
| M | 2020-09-30 | ATAO | Altair International Corp. | Erop Capital LLC | Owner of 9.4% of Issuer | S - Sale | $0.22 | -20,490 | 50,005,722 | 0% | -$4,508 | |||||
2020-10-01 | PEN | Penumbra Inc | Wilder Thomas | Dir | S - Sale | $196.06 | -115 | 3,908 | -3% | -$22,547 | ||||||
2020-10-01 | IRTC | Irhythm Technologies, Inc. | Day Mark J. | EVP, Research, Development | S - Sale | $230.17 | -17,500 | 20,479 | -46% | -$4,028,009 | ||||||
2020-10-01 | BSX | Boston Scientific Corp | Pierce David A | EVP Pres MedSurg | S - Sale | $38.56 | -2,282 | 2,690 | -46% | -$87,994 | ||||||
2020-10-05 | LUNG | Pulmonx Corp | Florin Daniel P | Dir | P - Purchase | $19.00 | +15,789 | 15,789 | New | +$299,991 | ||||||
| D | 2020-10-05 | LUNG | Pulmonx Corp | Ferrari Richard M | Dir | P - Purchase | $19.00 | +13,157 | 1,248,508 | +1% | +$249,983 | |||||
2020-10-05 | LUNG | Pulmonx Corp | Melenikiotou Georgia | Dir | P - Purchase | $19.00 | +26,315 | 26,315 | New | +$499,985 | ||||||
| D | 2020-10-05 | LUNG | Pulmonx Corp | Mead Dana G Jr. | Dir | P - Purchase | $19.00 | +26,315 | 1,550,424 | +2% | +$499,985 | |||||
2020-10-02 | DRIO | Dariohealth Corp. | Stern Adam K | Dir | P - Purchase | $0.00 | +619 | 40,396 | +2% | +$0 | ||||||
2020-10-01 | ATRC | Atricure, Inc. | Collar Mark A | Dir | S - Sale | $40.20 | -670 | 86,188 | -1% | -$26,934 | ||||||
2020-10-01 | GNMK | Genmark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering, Tech Dev | S - Sale | $14.46 | -500 | 210,265 | 0% | -$7,230 | ||||||
| D | 2020-10-01 | VAPO | Vapotherm Inc | 3X5 Partners, LLC | 10% | S - Sale+OE | $29.00 | -20,689 | 2,665,984 | -1% | -$599,981 | |||||
| M | 2020-09-30 | DXCM | Dexcom Inc | Pacelli Steven Robert | EVP Strategy, Corporate Dev | S - Sale | $411.20 | -2,200 | 63,018 | -3% | -$904,637 | |||||
| D | 2020-10-01 | SILK | Silk Road Medical Inc | Davis Andrew S. | Chief Commercial Officer | S - Sale+OE | $65.60 | -6,635 | 19,802 | -25% | -$435,239 | |||||
2020-10-01 | RMD | Resmed Inc | Sodhi Rajwant | Pres, SaaS Business | S - Sale | $172.84 | -1,500 | 32,589 | -4% | -$259,260 | ||||||
2020-10-01 | RMD | Resmed Inc | Hollingshead James | Pres, Sleep Business | S - Sale | $170.43 | -2,400 | 90,002 | -3% | -$409,023 | ||||||
| D | 2020-10-01 | VAPO | Vapotherm Inc | Walrod Nicholas T. | 10% | S - Sale+OE | $29.00 | -20,689 | 2,666,487 | -1% | -$599,981 | |||||
| D | 2020-10-01 | VAPO | Vapotherm Inc | Arnerich Anthony L. | Dir, 10% | S - Sale+OE | $29.00 | -20,689 | 2,676,288 | -1% | -$599,981 | |||||
2020-09-30 | INFU | Infusystem Holdings, Inc | Ruiz Thomas Mark | Chief Commercial Officer | S - Sale | $11.95 | -64,745 | 963 | -99% | -$773,703 | ||||||
| M | 2020-06-11 | HJLI | Hancock Jaffe Laboratories, Inc. | Biodyne Holding, S.A. | Former 10% Owner | S - Sale | $0.40 | -1,950,000 | 1,405,433 | -58% | -$787,036 | |||||
| M | 2020-09-30 | SWAV | Shockwave Medical, Inc. | Papiernik Antoine | Dir | S - Sale | $75.32 | -17,744 | 1,515,907 | -1% | -$1,336,514 | |||||
| A | 2020-09-16 | CRY | Cryolife Inc | Mackin James P | Pres, CEO | P - Purchase | $16.74 | +7,500 | 264,274 | +3% | +$125,524 | |||||
| M | 2020-09-28 | INFU | Infusystem Holdings, Inc | Meridian Ohc Partners, LP | Dir, 10% | S - Sale | $13.91 | -82,904 | 2,740,183 | -3% | -$1,153,029 | |||||
| D | 2020-09-29 | TNDM | Tandem Diabetes Care Inc | Hansen Brian B | EVP, CHIEF COMMERCIAL OFFICER | S - Sale+OE | $112.75 | -4,489 | 4,665 | -49% | -$506,135 | |||||
2020-09-25 | LMAT | Lemaitre Vascular Inc | Lemaitre George W | COB, CEO, 10% | S - Sale | $33.98 | -724 | 2,982,654 | 0% | -$24,599 | ||||||
| M | 2020-09-28 | SWAV | Shockwave Medical, Inc. | Papiernik Antoine | Dir | S - Sale | $73.95 | -30,603 | 1,533,651 | -2% | -$2,263,051 | |||||
| D | 2020-09-25 | TFX | Teleflex Inc | Klasko Stephen K. M.D. | Dir | S - Sale+OE | $326.15 | -200 | 1,121 | -15% | -$65,230 | |||||
| D | 2020-09-25 | NVCR | Novocure Ltd | Weinberg Uri | Chief Science Officer | S - Sale+OE | $103.35 | -15,250 | 27,597 | -36% | -$1,576,088 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |